Earlier this month, Apogee Therapeutics announced positive interim Phase 1 results for APG333, revealing it was well tolerated in healthy…
Read More

Earlier this month, Apogee Therapeutics announced positive interim Phase 1 results for APG333, revealing it was well tolerated in healthy…
Read More